Cargando…
Development of a Novel Anti-CD44 Variant 6 Monoclonal Antibody C(44)Mab-9 for Multiple Applications against Colorectal Carcinomas
CD44 is a cell surface glycoprotein, and its isoforms are produced by the alternative splicing with the standard and variant exons. The CD44 variant exon-containing isoforms (CD44v) are overexpressed in carcinomas. CD44v6 is one of the CD44v, and its overexpression predicts poor prognosis in colorec...
Autores principales: | Ejima, Ryo, Suzuki, Hiroyuki, Tanaka, Tomohiro, Asano, Teizo, Kaneko, Mika K., Kato, Yukinari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965047/ https://www.ncbi.nlm.nih.gov/pubmed/36835416 http://dx.doi.org/10.3390/ijms24044007 |
Ejemplares similares
-
A Novel Anti-CD44 Variant 9 Monoclonal Antibody C(44)Mab-1 Was Developed for Immunohistochemical Analyses against Colorectal Cancers
por: Tawara, Mayuki, et al.
Publicado: (2023) -
Development of a Novel Anti-CD44 Variant 4 Monoclonal Antibody C(44)Mab-108 for Immunohistochemistry
por: Suzuki, Hiroyuki, et al.
Publicado: (2023) -
Development of a Novel Anti-CD44 Variant 8 Monoclonal Antibody C(44)Mab-94 against Gastric Carcinomas
por: Suzuki, Hiroyuki, et al.
Publicado: (2023) -
Development of a Novel Anti-CD44 Variant 5 Monoclonal Antibody C(44)Mab-3 for Multiple Applications against Pancreatic Carcinomas
por: Kudo, Yuma, et al.
Publicado: (2023) -
Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, C(44)Mab-34, for Multiple Applications against Oral Carcinomas
por: Suzuki, Hiroyuki, et al.
Publicado: (2023)